Updated: September 24, 2026 | 16-minute read
You use a red light panel near a sore shoulder and wonder whether enough light reaches the tissue you have in mind. Wavelength matters, but so do measured output, distance, and the tissue between the device and the target.
Near-infrared light around 810–860 nm often experiences less attenuation in soft tissue than visible red light near 630 nm, making it a common choice for studying deeper targets. There is no single wavelength that penetrates deepest in every tissue and illumination setup: melanin, blood, water, scattering, beam geometry, and the definition of "penetration depth" all matter. In particular, 1064 nm is also near-infrared and cannot be dismissed simply because it lies above 1000 nm.
Understanding why wavelength and measured optical output both matter changes how you evaluate a device specification sheet. This guide explains what light therapy penetrates the deepest under stated conditions, how to interpret depth claims, and which device measurements to request.
Why penetration depth begins with the physics of light, not the device
Near-infrared light around 810–860 nm generally offers a useful combination of relatively low absorption and reduced scattering for some deeper soft-tissue applications. That optical advantage cannot, by itself, predict a treatment outcome. LED electrical watt ratings also do not measure light delivered to skin.
Illustrative skin cross-section comparing wavelength-dependent attenuation
Consider an athlete using a panel near a sore knee. A 630 nm channel may be attenuated more strongly by superficial tissues than an 850 nm channel, but that comparison alone cannot tell us the light exposure within the joint or predict relief. Source output, treatment geometry, pigmentation, and the thickness of overlying tissue also affect delivery. No result after several sessions does not establish that wavelength alone was the cause.
This is where the optical window helps. Biological tissue contains absorbers such as oxyhemoglobin, deoxyhemoglobin, melanin, and water. Across parts of the red and near-infrared spectrum, their combined absorption can be relatively low compared with neighboring bands, although the window's useful limits vary with tissue and application. Photons are also scattered, so an optical window does not guarantee delivery to any particular depth.
Three ranges are relevant here. Visible red (630–660 nm) is commonly studied for relatively superficial targets. Near-infrared around 810–860 nm is often studied where deeper soft-tissue delivery is sought; 1064 nm is another near-infrared research wavelength, with results that depend on tissue and beam geometry. Mid- and far-infrared sources used in sauna-format devices operate at substantially longer wavelengths, where water absorption and surface heating become more important. Light reaching farther does not automatically produce a better response.
Two optical processes limit delivery: absorption removes photon energy, while scattering changes photon direction. Their combined effects, along with reflection at the surface and the source's beam geometry, determine the distribution of light within tissue. "Penetration depth" should therefore refer to a specified measurement or model threshold, not a hard boundary beyond which no photons exist.
An internal production example illustrates why specifications need context. When the Production Department reviewed wiring terminal layouts in the chassis in late 2022, independent blue-light control increased terminal count from three to four for the series and to five for the 300 and 600 models. That is a control-system example, not a tissue-penetration experiment. It shows why adding an independently controlled wavelength also requires the corresponding electrical design and verification; its actual optical output still needs to be measured.
Understanding the optical window is the foundation for every wavelength decision that follows.
How far each wavelength actually travels: measured tissue penetration data
Qualitative wavelength comparison across skin, fat, and muscle
How deep does red light therapy actually penetrate, measured in millimeters?
There is no reliable universal millimeter figure for each wavelength across skin, fat, and muscle. A quoted depth might mean a 1/e attenuation depth, a point at which a detector still registers light, or a modeled fluence threshold; those are different quantities. Within the same tissue and geometry, near-infrared wavelengths around 810–860 nm frequently show an advantage over shorter visible-red wavelengths for deeper delivery. But 1064 nm remains a candidate in the near-infrared range: an ex vivo canine study measured greater transmission at 1064 nm than at 808, 915, and 975 nm under its conditions. That result does not establish the best wavelength for human joints. For the question "what light therapy penetrates the deepest?", ask in which tissue, with which source, and under which definition of depth?
Does near-infrared light actually reach the brain through the skull?
Some light can pass through scalp and skull, but only a small and highly variable fraction remains. In an ex vivo study of human cadaver heads, researchers measured 808 nm light within brain tissue using a specialized laser setup; this is not evidence that a general-purpose home LED panel provides a therapeutic brain dose. Simulations comparing 660, 810, and 1064 nm have also produced different wavelength rankings as their assumptions change. Transcranial photobiomodulation remains an active research field, and none of these results justify calling the brain entirely inaccessible to visible red or automatically reachable by an 850 nm consumer panel.
Several tissue variables shift the distribution independently of wavelength. Epidermal melanin can reduce delivery, particularly at shorter wavelengths; blood volume, water content, lipid content, tissue thickness, and scattering also matter. Adipose tissue and vascularized muscle have different optical properties, but neither is universally "transparent" to 850 nm. An anatomical path that passes through a thin layer of fat cannot be treated as equivalent to one that passes through several centimeters of muscle.
Penetration depth and biological response are related but distinct. Researchers have proposed local and downstream signaling pathways that could contribute to responses beyond the site where most light is absorbed; those proposals do not establish that a device delivered a therapeutic dose to a deep target. A measured response also does not reveal the fluence at a specific anatomical depth. Interpret optical measurements and clinical outcomes as separate forms of evidence.
Dissecting the scenario: what changed when the athlete switched to 850 nm
Illustrative comparison of 660 nm and 850 nm attenuation around a knee
Return to the athlete. Suppose the illumination geometry and measured incident optical irradiance for each channel were held comparable while the wavelength changed from 660 nm to 850 nm. What might shift in the tissue-light distribution? This is an illustrative comparison, not an observed treatment result.
Step 1: Identify where hemoglobin absorption peaks — and where it doesn't.
Oxyhemoglobin has prominent visible absorption bands, including around 540–580 nm. Its absorption is generally lower across portions of the near-infrared range, although deoxyhemoglobin, water, melanin, and scattering must also be considered. The resulting fluence at depth cannot be predicted from the hemoglobin curve alone. Tip: compare the complete tissue optical context rather than judging a wavelength by one absorber.
Step 2: Distinguish surface irradiance from fluence at depth.
The RDPRO 1500-ULTRA's published specification is >200 mW/cm² at 15 cm (approximately 6 inches) in its stated configuration, with a 660 nm/850 nm, 1:1 LED-count design. The irradiance figure describes a measurement plane 15 cm from the panel; it is not a measurement at 5 mm inside the knee. Likewise, the 1:1 LED count does not establish a 1:1 optical output from the two channels. To compare tissue delivery, record the separate channel outputs, illumination area, distance, and mode; then measure or model attenuation through the relevant tissues. Tip: compare irradiance readings only when their wavelength channels, geometry, and measurement methods are reported.
Step 3: Match wavelength to anatomical depth, not to device power.
Start with the location of the target and the overlying tissues, then compare relevant published protocols and the source's measured optical output. A 660 nm source can deliver light to superficial tissue; 850 nm may offer a different distribution in deeper soft tissue under comparable conditions. Neither wavelength alone establishes what reaches a knee or hip joint. Tip: for deep targets, request model-specific measurement data and avoid converting a skin-plane reading into an assumed joint dose.
These three steps — examining absorption and scattering, separating incident irradiance from internal fluence, and considering anatomy — make the comparison more useful when assessing a device. They do not replace a validated protocol or clinical evidence for a particular outcome.
Tissue-type variables that shift the answer for each person
Conceptual comparison of melanin-dependent 660 nm attenuation
Does skin pigmentation meaningfully change how deep red light penetrates?
Yes. Melanin absorbs across the visible and near-infrared spectrum, with wavelength-dependent attenuation that can alter the internal light distribution. An optical modeling study considered wavelength, illumination geometry, and skin tone together rather than assigning one depth to a skin-tone group. Although longer wavelengths may reduce some melanin-related attenuation, 850 nm delivery is not identical across individuals. These data do not establish a safe or effective session-time adjustment for any particular person; follow the device instructions and use outcome-specific evidence.
How does adipose tissue affect near-infrared delivery?
Fat and muscle differ in water, blood, and lipid content, which changes their absorption and scattering profiles. A layer of subcutaneous fat can therefore alter how 850 nm light is distributed, but it should not be described as universally transparent or assumed to transmit more than muscle under every measurement setup. Thickness and the optical properties of the entire tissue path matter.
Structural tissues add further complexity. Cartilage, synovium, and cortical bone have different optical and anatomical properties. Bone strongly attenuates light, yet "stops all transmission" is inaccurate: transcranial experiments have measured small amounts of light beyond human skull tissue. Whether a small joint receives a meaningful fluence through its overlying tissues cannot be established from wavelength alone. The same caution applies to assumptions about cellular uptake within cartilage.
For at-home users, joint geometry matters. Light reaching structures close to the skin is exposed to a different tissue path from light directed toward a hip beneath several centimeters of overlying tissue. Do not infer an "adequate" joint dose from the wavelength or skin-plane irradiance alone; the device, location, and intended outcome all need an appropriate evidence base.
Wavelength verification sits beneath all of these tissue-specific comparisons. A calibrated spectrometer or spectroradiometer covering the device's full emission range can report peak wavelength and spectral distribution; a lux meter or broadband power meter alone cannot identify the peak or spectral bandwidth. The measurement should identify the model, operating mode, drive condition, and instrument calibration. Broad spectral output can affect tissue interactions, but an emission tail above 900 nm is not automatically ineffective or fully absorbed.
How to read a device specification sheet for penetration-relevant data
Annotated device specification sheet showing wavelength and measurement conditions